About
Revo-i is Meere Company's flagship robotic-assisted surgical system, designed to bring minimally invasive surgery to new levels of precision and control. Developed as South Korea's homegrown answer to global surgical robots, the Revo-i system empowers surgeons across urological, gynecological, and colorectal specialties with a suite of cutting-edge technologies. The system features informative imaging through a high-definition 3D endoscope that provides surgeons with a clear, immersive view of the operative field. Advanced devices include multi-articulated (wristed) instruments that replicate and scale human hand movements with minimal tremor. The intuitive control console allows surgeons to operate with natural dexterity using ergonomic master controls. A virtual training platform enables surgical teams to practice and refine technique in a safe simulation environment before operating on patients. Revo-i is built for hospitals and surgical centers seeking to adopt robotic-assisted surgery with a domestically certified and internationally recognized system. As part of Meere Company's broader innovation portfolio—which also spans industrial sensor solutions and semiconductor/display equipment—Revo-i reflects the company's mission to advance human well-being through technology. It is CE marked and has received Korean FDA approval, making it a trusted choice for healthcare institutions looking to elevate surgical outcomes.
Key Features
- Informative Imaging: High-definition 3D endoscopic visualization gives surgeons an immersive, magnified view of the operative field for greater precision.
- Advanced Wristed Instruments: Multi-articulated instruments mimic and scale natural hand movements while filtering tremor, enabling delicate maneuvers in tight anatomical spaces.
- Intuitive Control Console: Ergonomic master controls translate the surgeon's hand, wrist, and finger movements into precise instrument actions with natural, low-fatigue operation.
- Virtual Surgical Training: A simulation-based virtual training platform allows surgeons and OR teams to rehearse procedures and build proficiency before live cases.
- Broad Surgical Application: Supports a range of minimally invasive specialties including urology, gynecology, and colorectal surgery with certified clinical validation.
Use Cases
- Hospitals adopting robotic-assisted surgery to improve outcomes in urological procedures such as radical prostatectomy.
- Gynecological surgical centers performing minimally invasive hysterectomies and myomectomies with greater precision.
- Colorectal surgery departments using robotic assistance to navigate complex pelvic anatomy with reduced complication rates.
- Surgical training programs leveraging the virtual simulation environment to credential new robotic surgeons efficiently.
- Healthcare institutions in South Korea and international markets seeking a CE-marked, domestically supported robotic surgical platform.
Pros
- Domestically Certified & Internationally Recognized: Revo-i holds Korean FDA approval and CE marking, validating its safety and efficacy for clinical use across multiple markets.
- Comprehensive Surgical Ecosystem: Combines imaging, instrumentation, control, and training in a single integrated platform, reducing the need for third-party solutions.
- Minimally Invasive Benefits: Enables smaller incisions, reduced blood loss, faster patient recovery, and shorter hospital stays compared to open surgery.
Cons
- High Capital Investment: As an enterprise medical device, Revo-i requires significant upfront procurement and installation costs, limiting accessibility for smaller facilities.
- Specialized Training Required: Surgeons and OR staff must complete dedicated credentialing and training programs before operating the system, adding onboarding time.
- Limited Global Installed Base: Compared to more established global competitors, Revo-i's installed base and long-term outcome data are still growing.
Frequently Asked Questions
What is the Revo-i surgical robot?
Revo-i is a robotic-assisted minimally invasive surgical system developed by Meere Company in South Korea. It provides surgeons with 3D HD visualization, wristed instrument control, and a simulation training environment for procedures in urology, gynecology, and colorectal surgery.
Which surgical specialties can use Revo-i?
Revo-i is approved and clinically validated for minimally invasive procedures in urology (e.g., radical prostatectomy), gynecology, and colorectal surgery, with ongoing expansion into other surgical disciplines.
Is Revo-i approved for clinical use?
Yes. Revo-i has received approval from the Korean Ministry of Food and Drug Safety (MFDS) and holds CE marking for use in European markets, confirming its safety and performance standards.
How does Revo-i compare to other surgical robots?
Revo-i offers capabilities comparable to global robotic surgical systems, including 3D imaging, multi-degree-of-freedom instruments, and tremor filtration. It is notable as a domestically developed Korean system with competitive pricing and local service support.
Does Revo-i include a training component?
Yes. The platform includes a virtual training module that allows surgeons to simulate procedures in a safe environment, supporting both initial credentialing and ongoing skill development without operating on patients.
